BCM
MRNS

Bridgeway Capital Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Bridgeway Capital Management’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-50,000
Closed -$88K – 1330
2024
Q3 		$88K Buy
+50,000
New +$69.8K ﹤0.01% 1169
2020
Q2 		– Sell
-69,650
Closed -$566K – 1415
2020
Q1 		$566K Sell
69,650
-23,950
-26% -$207K 0.01% 727
2019
Q4 		$809K Buy
93,600
+50,000
+115% +$281K 0.01% 797
2019
Q3 		$269K Sell
43,600
-2,800
-6% -$22.6K ﹤0.01% 1117
2019
Q2 		$770K Buy
46,400
+12,500
+37% +$217K 0.01% 824
2019
Q1 		$567K Buy
33,900
+15,973
+89% +$230K 0.01% 994
2018
Q4 		$206K Sell
17,927
-10,000
-36% -$202K ﹤0.01% 1214
2018
Q3 		$1.12M Buy
27,927
+13,525
+94% +$385K 0.01% 840
2018
Q2 		$407K Buy
+14,402
New +$319K ﹤0.01% 1193
2017
Q2 		– Sell
-7,500
Closed -$53K – 1483
2017
Q1 		$53K Hold
7,500
– – ﹤0.01% 1361
2016
Q4 		$30K Hold
7,500
– – ﹤0.01% 1391
2016
Q3 		$55K Sell
7,500
-11,375
-60% -$76.9K ﹤0.01% 1400
2016
Q2 		$96K Buy
18,875
+6,250
+50% +$115K ﹤0.01% 1384
2016
Q1 		$272K Hold
12,625
– – ﹤0.01% 1235
2015
Q4 		$386K Buy
12,625
+2,000
+19% +$58.7K 0.01% 1141
2015
Q3 		$354K Buy
10,625
+3,125
+42% +$176K 0.01% 1169
2015
Q2 		$348K Buy
+7,500
New +$280K 0.01% 1206

Other funds holding MRNS

BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bridgeway Capital Management's MRNS Position: Q4 2024 in Review

Bridgeway Capital Management sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q4 2024, closing a stake of 50,000 shares — an estimated $88K sold.

Bridgeway Capital Management first reported a position in MRNS in Q2 2015 and held it in 17 quarters. The position peaked at $1.12M in Q3 2018. 53 funds tracked by Wall St. Rank hold MRNS as of Q4 2024.

  • Bridgeway Capital Management reported no remaining Marinus Pharmaceuticals, Inc position as of Q4 2024 after selling out during the quarter.
  • Bridgeway Capital Management sold 50,000 Marinus Pharmaceuticals, Inc shares in Q4 2024, an estimated $88K.
  • Bridgeway Capital Management first reported a position in Marinus Pharmaceuticals, Inc in Q2 2015 and held it in 17 quarters.
  • Bridgeway Capital Management's Marinus Pharmaceuticals, Inc position peaked at $1.12M in Q3 2018.
  • 53 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q4 2024.

Based on Bridgeway Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.